Latigo Biotherapeutics
Clinical trials sponsored by Latigo Biotherapeutics, explained in plain language.
-
First human tests begin for experimental drug LTG-001
Knowledge-focused Recruiting nowThis is the first study testing a new drug called LTG-001 in people. Researchers want to see if it's safe and how the body handles it when given as a pill or through an IV. The study involves 204 healthy adults who will receive either the drug or a placebo. The main goal is to fi…
Phase: PHASE1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
New Pill's first human test: safety and pain response study
Knowledge-focused Recruiting nowThis is the first study testing a new oral medication called LTG-321 in humans. Researchers will give healthy volunteers increasing doses to check for safety, see how the body processes the drug, and measure its effects on pain tolerance using a cold water test. The goal is to ga…
Phase: PHASE1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC